Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Patent 12016842 was granted and assigned to Genentech on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 26 Jun, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 26 Jun, 2024
Edits made to:
Infobox (+91 properties)
Article (+263 characters)
‌

 US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Article

Patent abstract

Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using immunoconjugates comprising anti-CD79b antibodies in combination with additional therapeutic agents.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Genentech
Genentech
0
Current Assignee
Genentech
Genentech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120168420
Patent Inventor Names
Andrew Polson0
Dan Lu0
Jamie Harue Hirata0
Michael Wenger0
Shang-Fan Yu0
Yu-Waye Chu0
Date of Patent
June 25, 2024
0
Patent Application Number
172308610
Date Filed
April 14, 2021
0
Patent Citations
‌
US Patent 7090843 Recombinant anti-CD30 antibodies and uses thereof
0
‌
US Patent 7091186 None
0
‌
US Patent 7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
0
‌
US Patent 7098305 Sustained release of microcrystalline peptide suspensions
0
‌
US Patent 7098308 Pentapeptide compounds and uses related thereto
0
‌
US Patent 7202346 Antibodies to non-shed Muc1 and Muc16, and uses thereof
0
‌
US Patent 7276372 Antibodies against GPR64 and uses thereof
0
‌
US Patent 7288248 Antibodies against cancer antigen TMEFF2 and uses thereof
0
‌
US Patent 7303749 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
0
‌
US Patent 7312343 Synthesis of α-amino-β-alkoxy-carboxylic acid esters
0
‌
US Patent 7375078 Heterocyclic self-immolative linkers and conjugates
0
‌
US Patent 7399469 Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
0
‌
US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 7521541 Cysteine engineered antibodies and conjugates
0
‌
US Patent 7553816 None
0
‌
US Patent 7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
0
‌
US Patent 7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
0
‌
US Patent 7662387 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
0
‌
US Patent 7662936 Mass spectrometry of antibody conjugates
0
‌
US Patent 7737259 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling
0
‌
US Patent 7745394 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 7750116 Antibody drug conjugate metabolites
0
‌
US Patent 7754681 Heterocyclic self-immolative linkers and conjugates
0
‌
US Patent 7803915 Antibody compositions for the diagnosis and treatment of tumor
0
‌
US Patent 7829531 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
0
‌
US Patent 7837980 Partially loaded antibodies and methods of their conjugation
0
‌
US Patent 7851437 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
0
‌
US Patent 7855275 Cysteine engineered antibodies and conjugates
0
‌
US Patent 7892550 Anti-cmet antibodies
0
‌
US Patent 7947839 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
0
‌
US Patent 7964566 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 7964567 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 7968687 CD19 binding agents and uses thereof
0
‌
US Patent 7989434 Heterocyclic self-immolative linkers and conjugates
0
‌
US Patent 7994135 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 8067544 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
0
‌
US Patent 8088378 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 8088387 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
0
‌
US Patent 8142784 Antibody-drug conjugates and methods
0
‌
US Patent 8198417 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
0
‌
US Patent 8263083 Combination therapy with antibody-drug conjugates
0
‌
US Patent 8288352 Auristatins having an aminobenzoic acid unit at the N terminus
0
‌
US Patent 8309300 Cysteine engineered antibodies and conjugates
0
‌
US Patent 8343928 Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus
0
‌
US Patent 8455622 Variant target binding agents and uses thereof
0
‌
US Patent 8470329 Combination therapy with antibody-drug conjugates
0
‌
US Patent 8512707 Methods of treating drug-resistant cancers
0
‌
US Patent 8545850 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 8557780 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 8663642 Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders
0
‌
US Patent 8691531 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 8703714 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 8722857 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 8742076 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
0
‌
US Patent 8906376 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
0
‌
US Patent 9345785 Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates
0
‌
US Patent 9845355 Humanized anti-CD79b antibodies and immunoconjugates and methods of use
0
‌
US Patent 9896506 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 9975949 Anti-CD79b antibodies and methods of use
0
‌
US Patent 10077318 Cysteine engineered antibodies and conjugates
0
‌
US Patent 10494432 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 10544218 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 10981987 Humanized anti-CD79b antibodies and immunoconjugates and methods of use
0
‌
US Patent 11000510 Methods of using anti-CD79b immunoconjugates
0
‌
US Patent RE48558 Anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 11648317 Stable anti-CD79B immunoconjugate formulations
0
‌
US Patent 6884869 Pentapeptide compounds and uses related thereto
0
‌
US Patent 6913748 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
0
‌
US Patent 7052873 Natural human antibody
0
‌
US Patent 7053186 Antibodies immunospecific for STEAP1
0
Patent Primary Examiner
‌
Sheela J. Huff
0
CPC Code
‌
C07K 16/3061
0
‌
C07K 16/2887
0
‌
A61K 2300/00
0
‌
A61K 47/6889
0
‌
A61K 39/39558
0
‌
A61P 35/00
0

Find more entities like US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.